Auxilium Pharmaceuticals Inc. (AUXL)

[surf1944]

7:02AM Auxilium Pharma announces results from 3 year CORDLESS extension study in dupuytren's contracture (AUXL) 19.61 : Co says 34.8% of joints that had achieved clinical success had experienced recurrence. Of those patients with affected MP joints, 26.6% of joints that had achieved clinical success had recurrence through three years, while 56.4% of PIP joints that had achieved clinical success had recurrence through three years. In addition, -93% of joints that were successfully treated with XIAFLEX did not receive any medical or surgical intervention through three years of follow-up.